Sort   by:  
 Page size 
UnknownImmediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
Not available
S-EPMC8005111 | biostudies-literature
UnknownAn integrated clinico-metabolomic model improves prediction of death in sepsis.
Not available
S-EPMC3924586 | biostudies-literature
UnknownDepressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.
Not available
S-EPMC3806339 | biostudies-literature
UnknownCAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
Not available
S-EPMC3306163 | biostudies-literature
UnknownMacular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4998967 | biostudies-literature
UnknownPredominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893 | biostudies-literature
UnknownThiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276 | biostudies-literature
UnknownRanibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322 | biostudies-literature
UnknownSporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065 | biostudies-literature
UnknownRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193 | biostudies-literature
Sort   by:  
 Page size